Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
- PMID: 26579288
- PMCID: PMC4150578
- DOI: 10.1016/j.aju.2011.06.008
Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
Abstract
Objective: To investigate the effect of chronic use of sildenafil and intracavernous injection (ICI) with trimix in men not responding to on-demand monotherapy with sildenafil or ICI with prostaglandin-E1 (PGE1).
Patients and methods: The study included 40 patients with erectile dysfunction (ED), with a mean (SD) age of 50.7 (11.3) years and unresponsive to on-demand sildenafil or ICI with PGE1 as monotherapy. They were assessed using the Sexual Health in Men (SHIM)-5 score for ED severity, penile colour Doppler ultrasonography (CDUS) for peak systolic velocity (PSV), end-diastolic velocity (EDV) and resistance index (RI) with an ICI test using 0.25 mL of trimix of papaverine, PGE1 and phentolamine. Testosterone, prolactin and cholesterol levels were assessed. Patients received 25 mg sildenafil daily for 8 weeks, combined with twice weekly ICI with 0.25 mL of trimix. After treatment, the Erection Hardness Score (EHS), penile CDUS with ICI and ED Inventory of Treatment Satisfaction were assessed.
Results: The mean (SD) SHIM-5 score before treatment was 8.3 (0.5) in 15 of the 40 men and 6.3 (0.4) in 25. Penile haemodynamics were normal in five (13%), showed arterial insufficiency in five (13%), venous occlusive disease in 26 (65%) and mixed vascular in four (10%). There was an improved SHIM-5 score in 28 (70%) patients, as shown by their haemodynamic values, duration of erection and EHS with therapy, and 66% satisfaction with treatment. Adverse effects (penile pain, headache, facial flushing, dyspepsia, nasal congestion, dizziness) were reported in 17 patients (43%).
Conclusion: Chronic use of trimix plus daily low-dose sildenafil improved penile haemodynamics in these patients with ED not responding to on-demand phosphodiesterase-5 inhibitors or ICI with PGE1 monotherapy.
Keywords: CDUS, colour Doppler ultrasonography; ED, erectile dysfunction; EDITS, Erectile Dysfunction Inventory of Treatment Satisfaction; EDV, end-diastolic velocity; EH(S), Erection Hardness (Score); Erectile dysfunction; ICI, intracavernous injection; Intracavernous; NO, nitric oxide; PDE, phosphodiesterase; PDE-5I; PGE1; PGE1, prostaglandin E1; PSV, peak systolic velocity; RI, resistance index; SHIM, Sexual Health Inventory for Men; Therapy; VOD, veno-occlusive dysfunction.
Similar articles
-
Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction.BJU Int. 2008 Sep;102(8):993-7. doi: 10.1111/j.1464-410X.2008.07712.x. Epub 2008 May 12. BJU Int. 2008. PMID: 18476965 Clinical Trial.
-
Diagnostic categorization of erectile dysfunction using duplex color doppler ultrasonography and significance of phentolamine redosing in abolishing false diagnosis of venous leak impotence: A single center experience.Indian J Radiol Imaging. 2020 Jul-Sep;30(3):344-353. doi: 10.4103/ijri.IJRI_419_19. Epub 2020 Oct 15. Indian J Radiol Imaging. 2020. PMID: 33273769 Free PMC article.
-
Evaluation of the sensitivity of different doses of vasoactive drugs in diagnosing erectile dysfunction in impotent patients: a prospective case-control study.Cent European J Urol. 2021;74(1):109-115. doi: 10.5173/ceju.2021.00042.R1. Epub 2021 Feb 6. Cent European J Urol. 2021. PMID: 33976925 Free PMC article.
-
SOP conservative (medical and mechanical) treatment of erectile dysfunction.J Sex Med. 2013 Jan;10(1):130-71. doi: 10.1111/jsm.12023. J Sex Med. 2013. PMID: 23343170 Review.
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
References
-
- Lue T.F. Erectile dysfunction. N Eng J Med. 2000;342:1802–1813. - PubMed
-
- Lewis R.W., Fugl-Meyer K.S., Bosch R., Fugl-Meyer A.R., Laumann E.O., Lizza E. Epidemiology/risk factors of sexual dysfunction. J Sex Med. 2004;1:35–39. - PubMed
-
- Lue T.F., Giuliano F., Montorsi F., Rosen R.C., Andersson K.E., Althof S. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6–23. - PubMed
-
- Mulhall J.P., Goldstein I., Bushmakin A.G., Cappelleri J.C., Hvidsten K. Validation of the erection hardness score. J Sex Med. 2007;4:1626–1634. - PubMed
-
- Mulhall J.P., Althof S.E., Brock G.B., Goldstein I., Jünemann K.P., Kirby M. Erectile dysfunction. Monitoring response to treatment in clinical practice – recommendations of an international study panel. J Sex Med. 2007;4:448–464. - PubMed
LinkOut - more resources
Full Text Sources